Mergers & Acquisitions...
Merfeld & Schine, Inc.

Sell Your Business: No Upfront Fee


Selling your company may well be the largest financial transaction you ever make. It also may be one of the most complicated transactions you ever make. It's very important to get it right.


  • To successfully sell your business, it needs to be packaged and marketed both aggressively and confidentially.

  • The terms of the business sale can be as important as the selling price

  • The structure of a sale (or merger) can have a huge impact on your taxes and ultimately on the amount of money you can keep

  • Once you decide to sell your company, it needs to be handled discretely, efficiently, and expeditiously

  • And, during the entire process you need to keep running your business

We've learned a lot about mergers and acquisitions over the past 20+ years in business. Based upon our long experience, we offer a range of services to those considering selling a business.

Please take a look around our website. If you are contemplating selling a company or have related needs, you'll certainly find it helpful. Be sure to check out our step-by-step overview of how a business is sold. We charge no upfront fee for selling a business.



We focus on (but do not entirely limit to) companies with sales in the $1MM to $20MM range located in the New England States: MA, CT, NH, RI, VT, ME .

If any of our M&A services fit your needs, please feel free to contact us for a free consultation without obligations or sales pressure. Fill out this simple form or call us (401-751-3320)

Free initial consultation and evaluation for business sellers



PROVIDENCE
39 Brenton Ave.
Providence, RI 02906
Phone ~ 401-751-3320
Fax ~ 401-489-7339

E-Mail ~ brokers@mergers-acquisitions.com

Th a combination therapy (2-cda 0. 1 mg/kg sc injection and rituximab at standard schedule). Quantitation was performed using the delta ct calculation: the value of gene expression was normalised to the calibrator (healthy tissue cells). Results: hcnt1 and 5'nt gene expression analysis has shown lower values in pts than in controls. The other markers didn't show any significance. Two pts achieving partial remission (pr) presented c times lower hcnt1 levels (median 6. http://classicmotocrossimages.com/mbs-viagra-for-sale-generic-im/ 8*10-4, range 6. 8-6. 9*10-4) than pts (n=10) in complete remission (median 7. order viagra 9*10-2, range 0. 1-4. 6*10-1; p=0. 03). Conclusions: hcnt1 seems to be the most important gene involved in 2-cda clinical activity and its expression may correlate with prognosis. Compared to controls, the low plasmatic rna level of hcnt1 exhibited by our pts doesn't seem to be predictive of lack of clinical activity of 2-cda. However the lower level of hcnt1 plasmatic expression detected in the two pts who achieved only pr could suggest a possible relationship between reduced hcnt1 plasmatic expression and a diminished clinical activity of 2-cda. viagra use among young men Thus it might be important to explore the possibility of standardizing a quantitative method in order to identify a threshold value which could be predictive of drug resistance.   associated presentation(s):      no items found. how to get viagra over the counter   other abstracts in this sub-category:      1. viagra canada online Analysis of gemcitabine pathway genotypes in ethnic asians and their relationship with outcome in non-small cell lung cancer (nsclc) patients. viagra coupon Meeting: 2006 asco annual meeting   abstract no: 2008   first author: r. A. viagra use among young men Soo category: developmental therapeutics - experimental therapeutics - pharmacogenomics      2. Prognostic and predictive significance of 5-fluorouracil metabolic enzymes in colorectal cancer. Meeting: 2006 asco annual meeting   abstract no: 2021   first author: r. C. Soong category: developmental therapeutics - experimental therapeutics - pharmacogenomics      3. Association of molecular markers with toxicity outcomes in a randomized trial of chemotherapy for advanced colorectal cancer (focus). Meeting: 2006 asco annual meeting   abstract no: 2022   first author: m. T. Seymour category: developmental therapeutics - experimental therapeutics - pharmacogenomics      more... viagra without prescription   abstracts by c. Rabascio:      1. Hcnt1 in waldenström's macroglobulinemia (wm) and small lymphocytic lymphoma (sll) patients (pts): a possible predictive biomarker of 2-chloro-2'-deoxyadenosine (2-cda) clinical activity. Meeting: 2006 asco annual meeting   abstract no: 13087   first author: c. viagra for women/free trial Rabascio category: developmental therapeutics - experimental therapeutics - pharmacogenomics      2. viagra sales in india Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast.
Other Locations